AMZN three-lens brief
Evidence-based stock research on AMZN. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 14.0pp over 30 days. · Debt-to-equity of 53.3 — balance-sheet-heavy.
- Outperforming SPY by 14.0pp over 30 days.
- Analyst mean target $311.55 — 18% above current (62 analysts).
- Debt-to-equity of 53.3 — balance-sheet-heavy.
AMZN closed at $265.10 (-0.27%) as of 2026-05-13. Market cap: $2.85T. P/E (trailing) 31.7. Positives: outperforming SPY by 14.0pp over 30 days.; analyst mean target $311.55 — 18% above current (62 analysts).. Concerns: debt-to-equity of 53.3 — balance-sheet-heavy.. Last quarter: Revenue $181.52B, net income $30.25B, free cash flow $9.81B.
Why three lenses on AMZN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMZNacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AMZN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMZN brief"></iframe>